Bellafill® 5 Year Filler
Only FDA approved dermal filler for acne.
Do you love the youthful look that dermal fillers provide, but wish the results weren’t so temporary?
Bellafill® 5 Year Filler is a smooth collagen-based dermal filler with polymethylmethacrylate (PMMA) microspheres that lasts up to 5 years. The collagen gel in Bellafill® provides immediate volume and lift to correct the wrinkle/nasolabial fold and/or acne scar. The PMMA microspheres remain in place and create a base that provides structural support for smoother-looking skin.1
Bellafill® has been proven safe through 5 years in the largest and longest prospective dermal filler study ever conducted.2*
Come experience Bellafill® at Atlantis Medical Wellness Center in Silver Spring, MD.
Will it work for me?
In a clinical trial, Bellafill® was shown to work equally well with all skin types, and in men and women. If you have had a positive reaction to the Bellafill Skin Test, have a history of severe allergies, have known bovine collagen allergies, are allergic to lidocaine, have bleeding disorders or are prone to thick scar formation and/or excessive scarring, you should not receive Bellafill.
What’s the downtime?
You can return to normal activities right away. You may experience temporary swelling, redness, pain, bruising, lumps/bumps, itching, and discoloration at the treatment site. These side effects are usually transient and typically resolve within 1–7 days.2
Who can receive treatment with Bellafill®?
Patients must be 21 years of age or older, and receive the required negative skin test prior to treatment. In clinical studies, Bellafill® was shown to work in all skin types, and in men and women. If you have had a positive reaction to the Bellafill Skin Test, have a history of severe allergies, have known bovine collagen allergies, are allergic to lidocaine, have bleeding disorders, or are prone to thick scar formation and/or excessive scarring, you should not receive Bellafill. Please consult with your physician and refer to the Instructions for Use for a full list of contraindications.
How much does Bellafill® cost?
The cost of Bellafill® varies depending on how many syringes are required to obtain optimal correction. Your licensed provider can personalize a treatment plan that fits your time and budget during your consultation.
How long does it last?
Satisfaction and effectiveness for the correction of nasolabial folds have been established through 5 years. Effectiveness for the correction of acne scars has been proven through 12 months.2***
Bellafill® Acne Scar Correction
What is the physical and emotional impact of acne scars?
In a clinical trial, Bellafill® was shown to work equally well with all skin types, and in men and women. If you have had a positive reaction to the Bellafill Skin Test, have a history of severe allergies, have known bovine collagen allergies, are allergic to lidocaine, have bleeding disorders or are prone to thick scar formation and/or excessive scarring, you should not receive Bellafill.
Scars are more than skin deep, and have been shown to cause high levels of anxiety and self-consciousness.4
In an independent study 92% of people said if their acne scars were healed, it would restore or improve their self-confidence.5
Now with Bellafill®, acne scar sufferers have a new treatment choice approved by the FDA that is proven to be safe and effective with minimal to no downtime.
Sources:
1 Data on file. Suneva Medical, Inc.
2 Bellafill®[Instructions for Use]. San Diego, CA: Suneva Medical, Inc.; 2015
3 American Academy of Dermatology, http://www.aad.org/media-resources/stats-and-facts/conditions/acne#.Uc2hG_nvt8F.
4 Journal of Plastic, Reconstructive and Aesthetic Surgery, 2008, http://www.sciencedirect.com/science/article/pii/S1748681508003951.
5 Formula PR Independent Study, 2013.
*Proposed mechanism of action
**Based on 5 year post approval study on the correction of nasolabial folds.
***The indication for correction of nasolabial folds (smile lines) was approved based on a pivotal clinical study, where effectiveness was observed out to 12 months (primary effectiveness endpoint was at 6 months).
